Status:
UNKNOWN
Low Dose Steroids in the Treatment of Nephrotic Syndrome Relapse
Lead Sponsor:
Rabin Medical Center
Conditions:
Glomerular Disease
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Background- Idiopathic Nephrotic syndrome is the common glomerular disease in childhood. conventional treatment is steroid treatment and nearly 90% response to this treatment well. Response to this t...
Detailed Description
Idiopathic nephrotic syndrome in children is the most common chronic glomerular disease. The first line of therapy is prednisone and about 90% of the patients will response to this treatment. The cou...
Eligibility Criteria
Inclusion
- Patients with Idiopathic nephrotic syndrome with a flair that needs steroids treatment.
Exclusion
- Steroid resistance or treatment with Cyclosporin or Cellcept
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02216747
Start Date
September 1 2014
End Date
December 1 2015
Last Update
August 15 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shneider children Hospital Nephrology Institute
Petah Tikva, Israel